NEW DRUG PROPOSAL FROM WHO AGAINST COVID-19

Reading time is 1 mins

.
.
NEW DRUG PROPOSAL FROM WHO AGAINST COVID-19

The World Health Organization has updated its covid-19 patient care guidelines, noting that for severe cases, drugs in the interleukin-6 receptor blockers group have saved lives.

Drugs in the interleukin-6 receptor blockers group saved lives in severe and critical Covid-19 patients when used in combination with corticosteroids, the WHO said. Who stated that the findings were the result of the widest analysis they had conducted on drugs and that data from more than 10 thousand patients participating in 27 clinical trials were taken into account. The WHO statement highlighted that they were the first drugs found to be effective against Covid-19 after corticosteroids were recommended in September 2020.

Covid-19 cases in a pass heavy, the immune system usually Covid-19 and patients I had seen overreacting to this situation, but interleukin-6 with tocilizumab and sarilumab blocking drugs and medications, the patient stated that by acting to suppress these extreme reactions are prevented. In critical cases, the drugs reduced the mortality rate by 13 percent, the WHO said, meaning there would be 15 fewer deaths for every thousand patients and 28 fewer deaths for every thousand critical patients.

.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me
Latest posts by Medically Reviewed by Professor Doctor Alper Demirbaş (see all)